Essentia Health, with a clinic in Wahpeton, announced in a release on Tuesday that it will pause administration of the Johnson & Johnson COVID-19 vaccine.
Six reported cases of severe blood clotting in individuals who’d recently received the Johnson & Johnson vaccine are under review by the CDC and FDA.
Those cases — all of which were in women between 18-48 years old — have occurred since April 12; over that same time period, more than 6.8 million doses of the Johnson & Johnson vaccine have been distributed.
Those cases — all of which were in women between 18-48 years old — have occurred since April 12; over that same time period, more than 6.8 million doses of the Johnson & Johnson vaccine have been distributed.
According to a joint statement from the CDC and FDA: “Right now, these adverse events appear to be extremely rare. COVID-19 vaccine safety is a top priority for the federal government, and we take all reports of health problems following COVID-19 vaccination very seriously. People who have received the J&J vaccine who develop severe headache, abdominal pain, leg pain, or shortness of breath within three weeks after vaccination should contact their health care provider.”
This pause is not related to the effectiveness of the Johnson & Johnson vaccine. Nor does anyone who has received a Johnson & Johnson shot need to be revaccinated.
Essentia will continue to administer the Pfizer/BioNTech and Moderna vaccines to anyone aged 16 and older in the communities we serve. Pfizer/BioNTech and Moderna vaccines are a different type of vaccine and have not exhibited this rare risk in the tens of millions of doses given.
